MEETINGS Thursday 19th September 2019Advancements in pharmaceutical QC testing: dissolution and QbD testingRoyal Society of Chemistry, LondonWANT TO PRESENT A POSTER?
This one-day symposium will address issues and challenges associated with both dissolution and analytical QbD from a pharmacopoeial perspective. The first session will include overviews on the current/future state of dissolution testing from the regulators (MHRA), the British Pharmacopoeia (BP) and industry. It will be followed by a panel discussion. The role of statistical modelling in predicting dissolution issues will be discussed and finally the key question of how can we introduce meaningful pharmacopoeial dissolution specifications for modified release products, will be discussed.
The second session will focus on measurement uncertainty and analytical QbD from the regulators (MHRA), the British Pharmacopoeia (BP) and industry perspectives. This will be followed by a panel discussion.
This symposium will provide an excellent opportunity for dialogue, discussion and debate with speakers - several of whom have been very actively involved in shaping the various guidances - and the peer group in an open forum. Delegates will be able to understand, interpret and translate into day-to-day practice how the various guidelines are being interpreted by regulators and pharmacopoeias.
An excellent opportunity to learn from expert speakers involved in the interpretation and application of these key topics.Confirmed Speakers:
Dr Himal Makwana, BP
Dr James Mann, AZ
Dr Karin Boon, MHRA
Dr Gary Scrivens, Pfizer
Dr Himal Makwana, BP
Prof Clive Wilson, Strathclyde
Dr Steve Maddocks, BP
Ms Elena Razzano, MHRA
Dr Phil Borman, GSKDOWNLOAD BROCHURE
There will be an opportunity to present posters on the broad subject area of the symposium, subject to acceptance of a submitted abstract. Click here
for details.NOT A MEMBER? IT'S FREE...
If you are a member of the RSC or RPS, you join JPAG for free,
and benefit from discounted prices.Click here
for details.REGISTER NOW...
Delegate fees include registration, documentation, lunch and refreshments.DELEGATE RATES:
Concession : £ 45.00
Exhibitor GOLD : £ 1200.00
Exhibitor SILVER : £ 850.00
Exhibitor-BRONZE : £ 700.00
Member : £ 195.00
Non-Member : £ 295.00
Student : £ 45.00
If you have any questions about the meeting, please contact us: email@example.com.
|Add the meeting to your calendar by clicking on this icon.|
(if it first downloads, you will need to double-click the download)
|Why not share this meeting with your friends?|
Send link: https://www.jpag.org/139
Please promote this event for us on your website or social media platform
JPAG Symposium: Advancements in pharmaceutical QC testing: dissolution and QbD testing / Thursday 19th September 2019 / Royal Society of Chemistry, LondonTITLE OF EVENT:
Advancements in pharmaceutical QC testing: dissolution and QbD testingDATE OF EVENT:
Thursday 19th September 2019EVENT LINK:
Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BAVENUE LINK:
Joint Pharmaceutical Analysis GroupWEB LINK:
Royal Pharmaceutical Society and Royal Society of ChemistryCONTACT:
Hon Events Secretary JPAG, firstname.lastname@example.orgSPEAKERS:
Dr Karin Boon - MHRA
Dr Philip Borman - GlaxoSmithKline
Stephen Maddocks - MHRA
Dr Himal Makwana - MHRA
Dr James Mann - AstraZeneca
Elena Razzano - MHRA
Dr Garry Scrivens - Pfizer
Prof Clive Wilson - University of Strathclyde
Stephen Young - MHRA
RETURN TO MEETINGS